Orexigen(R) Therapeutics to Speak at RBC Capital Markets Investor Conference Panel

SAN DIEGO, Dec. 8 Orexigen(R) Therapeutics, Inc.(Nasdaq: OREX), a biopharmaceutical company focused on the treatment ofobesity, today announced that the Company will be speaking at the RBC CapitalMarkets Investor Conference. The presentation will be a panel format, titled"Shrinking the Obesity Epidemic." The details are as follows:

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on thetreatment of obesity. The Company's lead combination product candidates areContrave, which is in Phase 3 clinical trials, and Empatic, which is in thelater stages of Phase 2 clinical development. Each product candidate isdesigned to act on a specific group of neurons in the central nervous systemwith the goal of achieving appetite suppression and sustained weight loss.Further information about the company can be found at http://www.orexigen.com.Date: Wednesday, December 10 Time: 11:00 a.m. - 11:55 a.m. Eastern Location: Westin Times Square Hotel, New York

SOURCE Orexigen Therapeutics, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...